BOSTON, MA—Rates of adverse outcomes at 30 days are low among patients with symptomatic severe aortic stenosis who undergo TAVI with the self-expanding Portico valve (Abbott), with the newer FlexNav ...

• New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases • The minimally invasive Portico procedure allows doctors to treat severe aortic ...

St. Jude Medical (NYSE:STJ) announced Monday that it has received CE Mark for its Portico transcatheter aortic valve system for patients who are deemed too sick to undergo open heart surgery to ...

Medical devices major St. Jude Medical (NYSE:STJ - News) has reached another important clinical landmark by registering the first implant of its next-generation Portico transcatheter aortic heart ...

Medical devices major, St. Jude Medical, Inc.’s (STJ) recently won European CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve Implant (“TAVI”) and Transfemoral Delivery System.

Abbott is now entering a corner of the medical device space that has been dominated by Edwards Lifesciences and Medtronic. On Tuesday, the company earned FDA approval for its latest transcatheter ...

PARIS — Despite some potential advantages, transcatheter aortic valve implantation (TAVI) failed to meet the primary prespecified threshold for noninferiority to surgical aortic valve replacement in ...

May 2, 2012 (San Francisco, California)— Too many patients who cannot benefit from aortic-valve replacement are being treated with transcatheter valve implants, according to Dr Craig Miller (Stanford ...

CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed. In a ...

ABBOTT PARK, Ill., March 5, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for the new FlexNav™ delivery system for the company's Portico™ transcatheter aortic valve ...

ABBOTT PARK, Ill., March 5, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for the new FlexNav™ delivery system for the company's Portico™ transcatheter aortic valve ...